Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis R Roberts

Showing results (231-240 of 393) with videos related to

Pageof 40
Sort By:
Human Pathology|April 17, 2012
Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinomaBenjamin R Kipp, Jesse S Voss, Sarah E Kerr, et al.
Contemporary Clinical Trials|November 16, 2018
Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's Early Detection Research NetworkKelly A Borges, Jianliang Dai, Neehar D Parikh, et al.
JNCI Cancer Spectrum|March 21, 2023
Dietary inflammatory and insulinemic potential, risk of hepatocellular carcinoma, and chronic liver disease mortalityLu Long, Xing Liu, Jessica Petrick, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 29, 2017
Heat stress induced, ligand-independent MET and EGFR signalling in hepatocellular carcinomaScott M Thompson, Danielle E Jondal, Kim A Butters, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 28, 2019
Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysisSiddhartha Yadav, Hao Xie, Irbaz Bin-Riaz, et al.
Cancer Research|December 11, 2012
Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinomaJoachim C Mertens, Christian D Fingas, John D Christensen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 5, 2020
A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular CarcinomaNaga P Chalasani, Tiruvidaimarudur S Ramasubramanian, Abhik Bhattacharya, et al.
Molecular Cell|October 18, 2024
Opposing regulation of the STING pathway in hepatic stellate cells by NBR1 and p62 determines the progression of hepatocellular carcinomaSadaaki Nishimura, Juan F Linares, Antoine L'Hermitte, et al.
Journal of Cancer|March 5, 2020
Therapeutic Rationale to Target Highly Expressed Aurora kinase A Conferring Poor Prognosis in CholangiocarcinomaXiwei Ding, Tianlu Huang, Chunyan Peng, et al.
Cancers|October 27, 2022
Establishment and Characterization of a New Human Intrahepatic Cholangiocarcinoma Cell Line LIV27Xiwei Ding, Kais Zakharia, Catherine D Moser, et al.
Pageof 40

Showing results (231-240 of 393) with videos related to

Sort By:
Pageof 40
Human Pathology|April 17, 2012
Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinomaBenjamin R Kipp, Jesse S Voss, Sarah E Kerr, et al.
Contemporary Clinical Trials|November 16, 2018
Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's Early Detection Research NetworkKelly A Borges, Jianliang Dai, Neehar D Parikh, et al.
JNCI Cancer Spectrum|March 21, 2023
Dietary inflammatory and insulinemic potential, risk of hepatocellular carcinoma, and chronic liver disease mortalityLu Long, Xing Liu, Jessica Petrick, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 29, 2017
Heat stress induced, ligand-independent MET and EGFR signalling in hepatocellular carcinomaScott M Thompson, Danielle E Jondal, Kim A Butters, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 28, 2019
Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysisSiddhartha Yadav, Hao Xie, Irbaz Bin-Riaz, et al.
Cancer Research|December 11, 2012
Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinomaJoachim C Mertens, Christian D Fingas, John D Christensen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 5, 2020
A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular CarcinomaNaga P Chalasani, Tiruvidaimarudur S Ramasubramanian, Abhik Bhattacharya, et al.
Molecular Cell|October 18, 2024
Opposing regulation of the STING pathway in hepatic stellate cells by NBR1 and p62 determines the progression of hepatocellular carcinomaSadaaki Nishimura, Juan F Linares, Antoine L'Hermitte, et al.
Journal of Cancer|March 5, 2020
Therapeutic Rationale to Target Highly Expressed Aurora kinase A Conferring Poor Prognosis in CholangiocarcinomaXiwei Ding, Tianlu Huang, Chunyan Peng, et al.
Cancers|October 27, 2022
Establishment and Characterization of a New Human Intrahepatic Cholangiocarcinoma Cell Line LIV27Xiwei Ding, Kais Zakharia, Catherine D Moser, et al.
Pageof 40